The Bispecific T-Cell Engager Therapeutics Market is positioned for significant expansion as healthcare providers and pharmaceutical companies seek innovative approaches to treating complex diseases. The market is projected to increase from USD 7.7 billion in 2025 to USD 21 billion by 2035, with an estimated CAGR of 10.6%. The rising global prevalence of cancer is one of the primary...